Lates News

Nancy Ibach, Vice President of the Oncology Business Unit of MSD USA, stated that their cancer therapy Keytruda subcutaneous injection new dosage form is branded as Keytruda Qlex. Depending on the dosage, administration can be completed in just one to two minutes, whereas intravenous infusion typically takes about 30 minutes.